FOLH1 and neoplasm: By demonstrating that wb TMV quantified from PSMA PET/CT scans can predict survival outcomes even in patients with biochemical recurrence, our study provides novel evidence supporting the use of volumetric tumor assessment as an objective prognostic tool in earlier stages of disease.